The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, GE HealthCare Technologies Inc’s stock clocked out at $80.63, up 0.84% from its previous closing price of $79.96. In other words, the price has increased by $0.84 from its previous closing price. On the day, 3.08 million shares were traded. GEHC stock price reached its highest trading level at $81.27 during the session, while it also had its lowest trading level at $79.705.
Ratios:
To gain a deeper understanding of GEHC’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.23. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 1.14. In the meantime, Its Debt-to-Equity ratio is 1.08 whereas as Long-Term Debt/Eq ratio is at 0.86.
Upgrades & Downgrades
In the most recent recommendation for this company, Barclays on October 13, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $86.
On October 07, 2025, Citigroup Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $83.
UBS Upgraded its Sell to Neutral on May 05, 2025, while the target price for the stock was maintained at $73.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 24 ’25 when Kenneth Stacherski bought 4,585 shares for $77.00 per share.
Kenneth Stacherski bought 4,585 shares of GEHC for $361,993 on Oct 27 ’25. On Sep 22 ’25, another insider, Kenneth Stacherski, who serves as the Former Officer of the company, bought 19,524 shares for $74.46 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GEHC now has a Market Capitalization of 36812595200 and an Enterprise Value of 43694706688. As of this moment, GE’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.67, and their Forward P/E ratio for the next fiscal year is 16.28. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.31. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.81 while its Price-to-Book (P/B) ratio in mrq is 3.68. Its current Enterprise Value per Revenue stands at 2.158 whereas that against EBITDA is 12.05.
Stock Price History:
The Beta on a monthly basis for GEHC is 1.21, which has changed by -0.031122327 over the last 52 weeks, in comparison to a change of 0.12934029 over the same period for the S&P500. Over the past 52 weeks, GEHC has reached a high of $94.80, while it has fallen to a 52-week low of $57.65. The 50-Day Moving Average of the stock is 7.73%, while the 200-Day Moving Average is calculated to be 7.51%.
Shares Statistics:
It appears that GEHC traded 3.67M shares on average per day over the past three months and 5238310 shares per day over the past ten days. A total of 455.51M shares are outstanding, with a floating share count of 454.12M. Insiders hold about 0.31% of the company’s shares, while institutions hold 85.64% stake in the company. Shares short for GEHC as of 1763078400 were 9274066 with a Short Ratio of 2.53, compared to 1760486400 on 7918197. Therefore, it implies a Short% of Shares Outstanding of 9274066 and a Short% of Float of 2.69.
Earnings Estimates
A detailed examination of GE HealthCare Technologies Inc (GEHC) is currently in progress, with 15.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $1.01, with high estimates of $1.17 and low estimates of $0.92.
Analysts are recommending an EPS of between $4.59 and $4.51 for the fiscal current year, implying an average EPS of $4.55. EPS for the following year is $4.94, with 20.0 analysts recommending between $5.14 and $4.55.
Revenue Estimates
In. The current quarter, 15 analysts expect revenue to total $5.6B. It ranges from a high estimate of $5.7B to a low estimate of $5.47B. As of. The current estimate, GE HealthCare Technologies Inc’s year-ago sales were $5.32BFor the next quarter, 15 analysts are estimating revenue of $5.01B. There is a high estimate of $5.16B for the next quarter, whereas the lowest estimate is $4.93B.
A total of 20 analysts have provided revenue estimates for GEHC’s current fiscal year. The highest revenue estimate was $20.63B, while the lowest revenue estimate was $20.18B, resulting in an average revenue estimate of $20.49B. In the same quarter a year ago, actual revenue was $19.67BBased on 19 analysts’ estimates, the company’s revenue will be $21.42B in the next fiscal year. The high estimate is $21.86B and the low estimate is $21.11B.
